|
48 |
Differential proteins including complement factor H in the aqueous humor from patients with dry age-related macular degeneration (AMD)Hyewon Chung
|
|
49 |
Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement systemIkram Ayoub
|
|
50 |
Immunopathology of Terminal Complement Activation and Complement C5 Blockade Creating a Pro-survival and Organ-protective Phenotype in TraumaZhansheng Yang1, Miles Nunn2, Tuan Le1, Milomir Simovic1,3, Peter Edsall4, Bin Liu5, Johnny Barr5, Brian Lund4, Crystal Hill-Pryor6, Anthony Pusateri1, Leopoldo Cancio1, and Yansong Li1,3
|
|
51 |
The immune cell landscape of the injured brain and its relation to the complement system in traumatic brain injuryAmer Toutonji1, Carsten Krieg3, Davis Borucki3, Stephen Tomlinson3,5, and Silvia Guglietta4
|
|
52 |
Aspergillus fumigatus induces tumor necrosis factor release in a complement C3-dependent manner in lepirudin anticoagulated human whole bloodBeatrice Fageräng1,2,3, Maximilian P Götz2,3, Per Nilsson4,5, Tom E Mollnes1,6, and Peter Garred2,3
|
|
53 |
A Novel Functional Properdin Assay – Studying the Positive AP Regulator and Complement Amplification LoopSamuel Butler, Viktoria Kozma, Cecilia Månsson, Camilla Nilsson, Ali Qamar, Michael Schwenkert, and Therese Segerstein
|
|
54 |
C1-INH complexes as markers for classical and lectin pathway activationLisa Hurler1, Erika Kajdácsi 1, Erik J.M. Toonen2, Bregje van Bree2, György Sinkovits1, László Cervenak1, Reinhard Würzner3, and Zoltán Prohászka1,4
|
|
55 |
Correlation of systemic and in situ biomarkers of complement activation with histopathological features and prognosis in C3 glomerulopathy.Marie-Sophie Meuleman2, Anna Duval2, Véronique Frémeaux-Bacchi3, Jean-Paul Duong4, and Sophie Chauvet1
|
|
56 |
Glycan structure optimization of moss produced human complement factor H markedly improves pharmacokinetic and pharmacodynamics properties in vivo.Todor Tschongov1, Swagata Konwar1, Paulina Dabrowska-Schlepp2, Christian Sievert2, Andreas Busch2, Jens Peter Panse3,4, and Karsten Häffner1
|
|
57 |
Complement activation as a biomarker and pathogenic factor in rhabdomyolysis-induced acute kidney injuryidris Boudhabhay, Anne Grunenwald, and Lubka Roumenina
|
|
58 |
Involvement of PTX3 and MBL in the clearance of SARS-CoV-2 infected lung airway epithelial cellsHang Zhong1, Matteo Stravalaci1, Isabel Pagani2, Niloufar Kavian-Tessler1, Barbara Bottazzi1, Poli Guido2, Elisa Vicenzi2, and Cecilia Garlanda1
|
|
59 |
Complement Factor B activation test specificity in the rapid test format: generation and characterization of new Ba neo-epitope specific monoclonal antibodiesMollie O'Neill1, George Adegbuyi 1, Dan Mills1, Michelle Elvington2, Niamh O'Luanaigh1, and Martin Schmidt2
|
|
60 |
Determining the activity of the alternative and lectin path of the complement system in the fibrinogen coagulation test to predict of the severity of the COVID-19Batozhab Batozhargalovich Shoibonov
|
|
61 |
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an
anti-PEG hyperimmune pig model: Role of complement activation in cardiovascular, hematological and inflammatory mediator changes
Bálint A. Barta1, Tamas Radovits1, and Janos Szebeni2
|
